LncRNA GAPLINC Promotes Renal Cell Cancer Tumorigenesis by Targeting the miR-135b-5p/CSF1 Axis.

Wang, Siyuan; Yang, Xiaorong; Xie, Wenjie; Fu, Shengqiang; Chen, Qiang; Li, Zhilong; Zhang, Zhicheng; Sun, Ting; Gong, Binbin; Ma, Ming

Wang, Siyuan; Yang, Xiaorong; Xie, Wenjie; Fu, Shengqiang; Chen, Qiang; Li, Zhilong; Zhang, Zhicheng; Sun, Ting; Gong, Binbin; Ma, Ming.

Afiliação

Wang S; Department of Urology, The First Affiliated Hospital of Nanchang University, Nanchang, China.
Yang X; Department of Urology, The First Affiliated Hospital of Nanchang University, Nanchang, China.
Xie W; Department of Urology, The First Affiliated Hospital of Nanchang University, Nanchang, China.
Fu S; Department of Urology, The First Affiliated Hospital of Nanchang University, Nanchang, China.
Chen Q; Department of Urology, The First Affiliated Hospital of Nanchang University, Nanchang, China.
Li Z; Department of Urology, The First Affiliated Hospital of Nanchang University, Nanchang, China.
Zhang Z; Department of Urology, The First Affiliated Hospital of Nanchang University, Nanchang, China.
Sun T; Department of Urology, The First Affiliated Hospital of Nanchang University, Nanchang, China.
Gong B; Department of Urology, The First Affiliated Hospital of Nanchang University, Nanchang, China.
Ma M; Department of Urology, The First Affiliated Hospital of Nanchang University, Nanchang, China.

Front Oncol ; 11: 718532, 2021.

Article em En | MEDLINE | ID: mdl-34722262

Palavras-chave

CSF1; GAPLINC; long noncoding RNA; miR-135b-5p; renal cell carcinomas

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Front Oncol Ano de publicação: 2021 Tipo de documento: Article País de afiliação: China

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google